Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19.
Leukemia
; 34(4): 1202-1207, 2020 04.
Article
in En
| MEDLINE
| ID: mdl-31591467
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Introns
/
Leukemia
/
Frameshift Mutation
/
Immunotherapy, Adoptive
/
Antigens, CD19
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Leukemia
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2020
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom